The prevalence of hepatitis D in CHB patients in Baghdad city and its correlation with fibrosis

Musaab A. Almahdawi; Mahmood K. Saleh; Safaa A. A. Al-Waysi

doi:10.53730/ijhs.v6nS2.6155

Authors

Musaab A. Almahdawi Department of Biology, College of Education for Pure Sciences, Tikrit University, Iraq
Mahmood K. Saleh Department of Biology, College of Education for Pure Sciences, Tikrit University, Iraq
Safaa A. A. Al-Waysi Director of Gastroenterology Hepatology Hospital Laboratory, Ministry of Health, Iraq

Keywords:

CHB, HDV, fibrosis, fibroscan

Abstract

The aim of the study was to determine the prevalence of hepatitis D for chronic hepatitis B patients and to assess the degree of cirrhosis of hepatocytes. A study of 240 patients with CHB was studied in the laboratories of the Gastrointestinal Hospital, Dubai and Sama Dubai Specialized Medical Laboratories / Baghdad. Confirmatory examinations were conducted for them by conducting HBsAg test to ensure that they are infected with the viruses, HCV and HIV to ensure that there is no viral interference, and HDV IgG test was conducted by ELISA device to identify the male infected was (5) (31.2%) and the females was (11) (68.7%.( The results of fibrosis of the patients with hepatitis D viral showed different stages according to the severity of the infection, where it showed (S1). One infection with (6.25%) and the results of fibrosis (4.0) E(KPa), while (S2) the number of patients was (5) (21.25% ) and the incision of fibrosis ranged between (7.0 - 8.1) E(KPa), the (S3) showed the number of patients (6) (37.5%) and severity of fibrosis (8.4 -10.1) E(KPa), while (S4) which is considered to have severe fibrosis.

Downloads

Download data is not yet available.

References

Abbas, Z., & Afzal, R. (2013). Life cycle and pathogenesis of hepatitis D virus: A review. World journal of hepatology, 5(12), 666.‏

Afdhal NH. (2014) Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology. 37(5):972–974.

Al-faham, M. A. (2012). Duel-infection of Hepatitis B Virus and Hepatitis D Virus (HDV) in Iraqi Hemodialysis Patients. International Journal for Sciences and Technology, 7(2).‏

Al-Hilli, H. A., & Al-Ugaidy, Y. H. (2002). Prevalence of hepatitis delta virus super infection in chronic HBV infection. IJGE, 1(3), 30-33.‏

Braga, W. S. M., de Oliveira, C. M. C., de Araújo, J. R., da Costa Castilho, M., Rocha, J. M., de Lima Gimaque, J. B., ... & Paraná, R. (2014). Chronic HDV/HBV co-infection: Predictors of disease stage–a case series of HDV-3 patients. Journal of hepatology, 61(6), 1205-1211.‏

Brener, S. (2015). Transient elastography for assessment of liver fibrosis and steatosis: an evidence-based analysis. Ontario health technology assessment series, 15(18), 1.‏

Cadranel JF, Rufat P, Degos F.(2000). Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 32(3):477–481.

Chen H-Y,Shen D-T,Ji D-Z,et al. (2019) Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta analysis. Gut. 68(3):512-521. https://doi.org/10.1136/ gutjn l-2018- 316601.

Dastgerdi, E. S., Herbers, U., & Tacke, F. (2012). Molecular and clinical aspects of hepatitis D virus infections. World journal of virology, 1(3), 71.‏

de Ledinghen V, Vergniol J. (2008) Transient elastography (FibroScan). Gastroenterol Clin Biol. 32(6 Suppl 1):58-67.

Degertekin, H.; Yalcin, K.; Yakut, M. and Yurdaydin, C (2008). Seropositively for Delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta – analysis. Liver. Int., 28 (4): 494 – 498.

Fong, T. L., Lee, B. T., Chang, M., Nasanbayar, K., Tsogtoo, E., Boldbaatar, D., ... & Saito, T. (2021). High prevalence of chronic viral hepatitis and liver fibrosis among Mongols in Southern California. Digestive Diseases and Sciences, 66(8), 2833-2839.‏

Goyal A, Murray JM. (2014) The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology. PLoS One 9:e110143.

Habib, A., & Al-Obeidy, E. S. (2006). Delta virus infection in Iraq. IJGE, 1(6), 43-48.‏

Hadi, L. M., Hussein, A. A., & Ja'afer, A. M. (2017). Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq. Diyala Journal of Medicine, 13(1), 74-83.‏

Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. (2009). Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat. 16 (12):883-894.

Miao, Z., Zhang, S., Ou, X., Li, S., Ma, Z., Wang, W., ... & Pan, Q. (2020). Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. Journal of infectious diseases, 221(10), 1677-1687.‏

Pollicino T, Raffa G, Santantonio T, Gaeta GB, Iannello G, Alibrandi A, Squadrito G, Cacciola I, Calvi C, Colucci G, Levrero M, Raimondo G. (2011). Replicative and transcriptional activities of hepatitis B virus in patients co-infected with hepatitis B and hepatitis delta viruses. J. Virol. 85: 432-439.

Regev A, Berho M, Jeffers LJ, et al. (2002). Sampling error and intra observer variation in liver biopsy in patients with chronic HCV infection. Am J Gastro enterol. 97(10):2614–2618.

Salim, R. W., & Abdullah, B. A. (2014). The prevalence of hepatitis B virus in high risk groups in Nineveh governorate/Iraq. Baghdad Science Journal, 11(2), 888-893.‏

Tseng CH, Cheng TS, Shu CY, Jeng KS, Lai MM. (2010). Modification of small hepatitis delta virus antigen by SUMO protein. J Virol 84: 918-927.

Wang D, Pearlberg J, Liu YT, Ganem D. (2001). Deleterious effects of hepatitis delta virus replication on host cell proliferation. J Virol 75: 3600-3604.

Wedemeyer H. (2010). Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDV. J Hepatol. 52: 627-629.